Ispinesib (SB-715992) (Supplementary Fig. S1) is a potent and highly specific KIF11 inhibitor, and we have shown that it is active against GBM cells, including treatment resistant TICs, in vitro and against orthotopic GBM models in vivo7. Here, KIF11 is linked to glioblastoma.